Athersys, Inc. (ATHX) financial statements (2020 and earlier)

Company profile

Business Address 3201 CARNEGIE AVENUE
CLEVELAND, OH 44115-2634
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments40512915232632
Cash and cash equivalents40512915232632
Receivables 011011
Other undisclosed current assets2711000
Total current assets:42583116242733
Noncurrent Assets
Property, plant and equipment3323111
Other noncurrent assets  0    
Other undisclosed noncurrent assets21 000 
Total noncurrent assets:5423111
TOTAL ASSETS:47623419252934
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21266444
Accounts payable 945332
Accrued liabilities1001111
Employee-related liabilities1211111
Debt    0  
Deferred revenue and credits1 000
Other undisclosed current liabilities13430000
Total current liabilities:1515107554
Noncurrent Liabilities
Long-term debt and lease obligation     00
Long-term debt, excluding current maturities     00
Liabilities, other than long-term debt0 0    
Customer advances or deposits0    
Other liabilities0      
Total noncurrent liabilities:0 0  00
Total liabilities:1515107555
Stockholders' equity
Stockholders' equity attributable to parent, including:27432311202120
Common stock0000000
Treasury stock, value      (0)
Additional paid in capital435416374329323307284
Accumulated deficit(408)(373)(351)(318)(303)(287)(264)
Warrants and rights outstanding     310
Other undisclosed stockholders' equity attributable to parent     (3)(10)
Total stockholders' equity:27432311202120
Other undisclosed liabilities and equity53 11310
TOTAL LIABILITIES AND EQUITY:47623419252934

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues7244171222
Revenue, net4171222
Cost of revenue    (0)(0)(0)
Gross profit:7244171212
Operating expenses(53)(48)(36)(32)(29)(30)(27)
Other undisclosed operating loss(1)(1)(1)(0)   
Operating loss:(47)(25)(33)(15)(17)(29)(24)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
1100(0)00
Loss from continuing operations before equity method investments, income taxes:(46)(24)(33)(15)(17)(29)(24)
Other undisclosed income (loss) from continuing operations before income taxes  1(1)17 
Loss from continuing operations before income taxes:(46)(24)(32)(15)(16)(22)(24)
Income tax benefit   000 
Net loss:(46)(24)(32)(15)(16)(22)(24)
Other undisclosed net loss attributable to parent      (6)
Net loss available to common stockholders, basic:(46)(24)(32)(15)(16)(22)(31)
Dilutive securities, effect on basic earnings per share     (2) 
Other undisclosed net loss available to common stockholders, diluted    (0)  
Net loss available to common stockholders, diluted:(46)(24)(32)(15)(17)(24)(31)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(46)(24)(32)(15)(16)(22)(24)
Comprehensive loss:(46)(24)(32)(15)(16)(22)(24)
Other undisclosed comprehensive loss, net of tax, attributable to parent      (6)
Comprehensive loss, net of tax, attributable to parent:(46)(24)(32)(15)(16)(22)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: